Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040210116

Enrollment

244

Registered

2021-12-25

Start date

2022-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Head and Neck Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Over 20 years old,Japanese, the first administration of cetuximab with chemotherapy or alone

Exclusion criteria

Exclusion criteria: The patients who have allergic reaction during chemotherapy administration on the same day

Design outcomes

Primary

Measure	Time frame
The exploratory factor analysis of the risk of cetuximab-related infusion reaction	—

Secondary

Measure	Time frame
the rate of cetuximab-related infusion reaction the percentage of infusion reaction onsets according to adverse event-grades the percentage of medical interventions according to adverse event-grades	—

Contacts

Public ContactChiharu Onoda

Yaizu City Hospital

chiharu.onoda@hospital.yaizu.shizuoka.jp+81-54-623-3111

Outcome results